Invention Grant
- Patent Title: Method for screening compounds which change the binding properties of a protein with a ligand
- Patent Title (中): 筛选用配体改变蛋白质的结合特性的化合物的方法
-
Application No.: US10499172Application Date: 2002-12-13
-
Publication No.: US07202040B2Publication Date: 2007-04-10
- Inventor: Masaaki Mori , Tomoko Chikatsu , Shuji Sato , Toshimi Nagi , Tsukasa Sugo
- Applicant: Masaaki Mori , Tomoko Chikatsu , Shuji Sato , Toshimi Nagi , Tsukasa Sugo
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Edwards Angell Palmer & Dodge LLP
- Agent David G. Conlin; Christine C. O'Day
- Priority: JP2001-382174 20011214; JP2002-200556 20020709
- International Application: PCT/JP02/13096 WO 20021213
- International Announcement: WO03/052414 WO 20030626
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/00 ; C12Q1/68 ; C12N15/00 ; A61K38/02 ; A61K38/16

Abstract:
The present invention relates to a screening method/screening kit for screening a compound or its salt that changes the binding properties of (a) a protein containing the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1 or SEQ ID NO: 19, its partial peptides, or salts thereof, and (b) a ligand capable of binding specifically to the protein; compounds obtained by the screening or salts thereof; pharmaceuticals comprising the compounds or salts thereof; a protein containing the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 19; etc. The compounds obtained by the screening of the present invention are useful as agents for the prevention/treatment of, for example, neurodegenerative diseases, immunological diseases, edema, acid indigestion, etc.
Public/Granted literature
- US20050154190A1 Screening method Public/Granted day:2005-07-14
Information query
IPC分类: